Do Circulation Supplements Actually Work? An Honest Look at the Evidence

Key Takeaways:

• Some circulation supplements have real but modest human evidence. Garlic, beetroot, magnesium, omega-3s, nattokinase, and vitamin K2 all have published trials behind them. Others, like ginkgo for leg circulation, have failed careful review.
• "Working" usually means single-digit changes in measured markers: a few mmHg of blood pressure, a shift in triglycerides, or improved arterial stiffness scores. It is not a sensation you feel.
• Two popular options have evidence against them: high-dose niacin added serious adverse events without reducing vascular events in a 25,673-person trial, and NIH warns that high-dose vitamin E can increase bleeding risk.
• No pill fixes poor circulation. If you have symptoms, get them evaluated by a doctor first; supplements support specific measured markers at best.
• Consult a physician before combining any circulation supplement with anticoagulant or antiplatelet medication.

Do Circulation Supplements Really Work?

The honest answer is that some circulation supplements can help, modestly, for specific measured outcomes, and some do not work at all. The best-studied options produce changes you can verify in a lab or a blood pressure cuff, not a feeling of "better flow."

Here is what the human research actually shows. A 2016 meta-analysis of 34 randomized trials found magnesium lowered systolic blood pressure by about 2 mmHg. A 2023 meta-analysis of 6 nattokinase trials found a 3.45 mmHg systolic reduction. Aged garlic extract trials report around 8 mmHg in people with elevated blood pressure who respond to it. These are real, statistically significant results. They are also small, and anyone promising more than that is selling past the evidence.

On the other side of the ledger, a Cochrane review found no clinically significant benefit from ginkgo biloba for peripheral artery disease, and a major randomized trial found high-dose niacin caused harm without cardiovascular benefit. "Circulation supplement" is a category, rather than an actual verdict, and each ingredient needs to earn its own case.

What Does "Working" Actually Mean for Circulation Supplements?

Before you can judge any supplement, it’s important to know what researchers measure. Circulation studies don’t measure how your legs feel, for example.

Instead, they measure things like:

• Blood pressure, in mmHg. A 3 to 5 mmHg reduction is a typical positive supplement result. For context, that’s a fraction of what lifestyle changes or medication can do, but it is measurable and repeatable.
• Blood lipids, like triglycerides in mg/dL. The NIH reports that each 1 g/day of long-chain omega-3s lowers triglycerides by roughly 5.9 mg/dL, based on an analysis of 58 trials.
• Arterial stiffness, using tools like pulse wave velocity, which tracks how flexible your arteries are.

The study design matters as much as the number. In plain English, here’s what to look out for:

• Randomized controlled trial (RCT): Participants are randomly assigned to the supplement or a placebo, ideally with neither side knowing which is which. This is the strongest design because it isolates the supplement's effect.
• Observational study: Researchers track what people already eat or take and look for associations years later. It’s useful, but it can only show association, not genuine causation.
• Open-label study: Everyone knows they’re taking the real thing, and there is no placebo group. Results are preliminary until an RCT confirms them.

When you see a bold claim, do some digging to see which of these produced it. Some supplement marketing quotes the weakest tier as if it were the strongest.

Which Circulation Supplements Have the Best Evidence?

Here’s the overview, graded.

*Nearly all garlic trials come from one industry-funded research program on a single branded extract, which is worth knowing when you weigh that 8.3 mmHg figure.

That said, there are a few things worth noting following the table:

• Beetroot's effect shows up in clinic readings, but a 2022 meta-analysis of beetroot in hypertensive patients found no significant effect on 24-hour blood pressure, so durability is unclear
• The triglyceride effect of omega-3s is well established, but evidence for hard cardiovascular outcomes is mixed.
• For vitamin K2, the famous Rotterdam Study finding (highest dietary K2 intake associated with 57% lower relative risk of heart-disease mortality across 4,807 adults) is observational, meaning association rather than proof; the stronger evidence is a 3-year double-blind RCT in 244 postmenopausal women where 180 mcg/day of MK-7 improved pulse wave velocity versus placebo.

Ultimately, none of these numbers are dramatic, but all of them are real, and that’s the honest ceiling of the category as studied so far.

What Does the Evidence Not Support?

So, now you know what the science says about a handful of common circulation supplements. But what does the research not support? There are three key findings you should know before spending money:

• Ginkgo biloba for leg circulation: null. The Cochrane review of 14 trials in 739 people with peripheral artery disease found ginkgo added about 64.5 meters of walking distance versus placebo, and concluded there is "no evidence that Ginkgo biloba has a clinically significant benefit." Ginkgo remains one of the most marketed "circulation herbs" anyway.
• High-dose niacin: evidence of harm. The HPS2-THRIVE trial randomized 25,673 statin-treated patients to extended-release niacin or placebo. Niacin added no reduction in major vascular events and increased serious adverse events, including new-onset diabetes (9.1% vs 7.3%) and bleeding (2.5% vs 1.9%). That is strong evidence against high-dose supplemental niacin, published in the New England Journal of Medicine.
• High-dose vitamin E: proceed with caution. The NIH Office of Dietary Supplements warns that high-dose vitamin E can increase bleeding risk. The upper limit is 1,000 mg/day, and "more antioxidants" is not a circulation strategy.

How Should You Evaluate Any Circulation Supplement?

There are four main filters that can help you catch (and avoid) most bad products and find the best supplements:

1. Look for exact doses on the label. Every ingredient with its amount, no proprietary blends. If you cannot see the dose, you cannot compare it to any study.
2. Look for doses that match the research. The magnesium trials used a median of 368 mg/day. The MK-7 stiffness trial used 180 mcg/day. Nattokinase blood pressure trials used 2,000 FU/day and up. A product with a fraction of a studied dose is borrowing evidence it did not earn.
3. Prioritize third-party testing that you can see. Published results, or shared promptly on request.
4. Choose based on realistic claims. The honest range is a few mmHg or a measurable marker shift over 8 weeks to 3 years. "Feel the flow in days" is a red flag, because that’s not what any of these studies measured.

Where Does Nattokinase Fit In All This?

At Toku, we sell a nattokinase supplement, so weigh this paragraph accordingly — but here’s the same treatment.

Nattokinase is an enzyme from fermented soybeans that breaks down fibrin in laboratory and preclinical studies. In humans, a 2023 meta-analysis of 6 randomized trials (546 participants) found modest reductions in blood pressure from nattokinase (-3.45 mmHg systolic, -2.32 mmHg diastolic) and no significant lipid effects at common doses.

A larger 12-month study of 10,800 FU/day in 1,062 participants reported improved lipids and reduced carotid plaque, but it was open-label with no placebo group, so those results are preliminary until confirmed in a randomized trial. Moderate evidence for a modest blood pressure effect, promising but unproven beyond that: that is the fair summary.

Our product, Toku Flow, pairs the studied 10,800 FU dose with vitamin K2 (MK-7) and oat beta-glucan, with exact amounts and third-party testing published, because those are the standards we just told you to demand.

One important safety note here: nattokinase, garlic, ginkgo, vitamin E, and vitamin K2 can all interact with blood thinners. Consult a physician before combining any supplement with anticoagulant or antiplatelet medication.

Parting Thoughts

If you came here doubting circulation supplements, your instinct was partly right. The category is full of underdosed products, borrowed evidence, and ingredients with null or negative trials. But the skepticism should be aimed at products, not at the entire idea: a handful of ingredients have modest, repeatable, measured effects in human trials. Know what "working" means, check the dose against the study, and talk to your doctor, especially if you take any medication.

*The information provided in this article is for educational and informational purposes only and is not intended as health or medical advice. Always consult a physician or other qualified health provider regarding any questions you may have about a medical condition or health objectives. This content has not been evaluated by the Food and Drug Administration and is not intended to diagnose, treat, cure, or prevent any disease.

Sources

1. Zhang et al., magnesium meta-analysis (34 RCTs), Hypertension, 2016. https://www.ahajournals.org/doi/10.1161/hypertensionaha.116.07664 
2. Nattokinase meta-analysis (6 RCTs, 546 participants), Reviews in Cardiovascular Medicine, 2023. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11266782/
3. Kim et al., nattokinase RCT, Hypertension Research, 2008. https://pubmed.ncbi.nlm.nih.gov/18971533/
4. Chen et al., 12-month open-label nattokinase study, Frontiers in Cardiovascular Medicine, 2022. https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2022.964977/full
5. Chen et al., nattokinase mechanism review, Biomarker Insights, 2018. https://pubmed.ncbi.nlm.nih.gov/30013308/
6. Ried, aged garlic extract meta-analysis, Experimental and Therapeutic Medicine, 2020. https://pubmed.ncbi.nlm.nih.gov/32010325/
7. Siervo et al., beetroot/nitrate review, Journal of Nutrition, 2013. https://pubmed.ncbi.nlm.nih.gov/23596162/
8. Beetroot meta-analysis in hypertensive patients, 2022. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965354/
9. NIH ODS, Omega-3 Fatty Acids fact sheet. https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/
10. Geleijnse et al., Rotterdam Study, Journal of Nutrition, 2004. https://www.sciencedirect.com/science/article/pii/S0022316623028961
11. Knapen et al., MK-7 arterial stiffness RCT, Thrombosis and Haemostasis, 2015. https://cris.maastrichtuniversity.nl/en/publications/menaquinone-7-supplementation-improves-arterial-stiffness-in-heal/
12. Nicolai et al., Cochrane review of ginkgo for PAD, 2013 (CD006888). https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006888.pub3/abstract
13. HPS2-THRIVE Collaborative Group, NEJM, 2014. https://www.nejm.org/doi/full/10.1056/NEJMoa1300955
14. NIH ODS, Vitamin E fact sheet. https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/
15. NCCIH, herb-drug interactions digest. https://www.nccih.nih.gov/health/providers/digest/herb-drug-interactions
16. Cleveland Clinic, iron deficiency anemia; vitamin deficiency anemia; B12 deficiency. https://my.clevelandclinic.org/health/diseases/22824-iron-deficiency-anemia, https://my.clevelandclinic.org/health/diseases/17732-vitamin-deficiency-anemia, https://my.clevelandclinic.org/health/diseases/22831-vitamin-b12-deficiency